Insulet Corporation (PODD) vs Smith & Nephew SNATS, Inc. (SNN)

Insulet Corporation and Smith & Nephew SNATS, Inc. are both Medical Devices companies. Smith & Nephew SNATS, Inc. is the larger, with a market value of $11.2B against $9.6B — 1.2× the size. Insulet Corporation trades at the lower P/E: 25.4× against 32.8×. Insulet Corporation grew revenue faster over the last twelve months: 29.4% against 4.81%. Insulet Corporation has the higher net margin (12.3% vs 6.71%) and the higher return on invested capital (17.6% vs 0.00%). Across the 22 metrics below, Insulet Corporation leads on 14 and Smith & Nephew SNATS, Inc. on 8.

Valuation

Metric PODD SNN Medical Devices median
P/E 25.44 32.80 22.18
P/S 3.09 1.15 2.70
P/B 6.63 2.33 2.46
Price to free cash flow 35.52 5.97 22.53
EV/EBITDA 16.01 5.66 11.78
EV/Sales 3.22 1.39 2.38
Earnings yield 3.93% 3.05% (8.22%)
Free cash flow yield 2.82% 16.74% (7.80%)

Profitability

Metric PODD SNN Medical Devices median
Gross margin 71.07% 70.52% 56.01%
Operating margin 16.89% 0.00% (15.03%)
Net margin 12.29% 6.71% (20.40%)
Free cash flow margin 8.70% 0.00% (7.24%)
Return on equity 26.02% 0.00% (15.32%)
Return on assets 11.31% 0.00% (19.72%)
Return on invested capital 17.56% 0.00% (10.33%)

Growth

Metric PODD SNN Medical Devices median
Revenue growth (TTM) 29.41% 4.81% 8.80%
EPS growth (last fiscal year) (39.79%) 52.34% —
Revenue growth, 5-year CAGR 24.53% 6.21% 15.23%
Net income growth, 5-year CAGR 105.15% 6.89% 0.00%

Health

Metric PODD SNN Medical Devices median
Debt to equity 0.67 0.62 0.07
Current ratio 2.48 2.14 2.50
Net debt to EBITDA 0.41 1.92 0.49

Dividend

Metric PODD SNN Medical Devices median
Dividend yield — 2.67% 0.94%
Payout ratio 0.00 1.50 0.00

Size

Metric PODD SNN Medical Devices median
Market cap 9.56b 11.17b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack